• Mon, September 9, 2024
Eric Schmidt Reiterated (BIIB) at Buy and Held Target at $292 on, Sep 9th, 2024
Eric Schmidt of Cantor Fitzgerald, Reiterated "Biogen Inc." (BIIB) at Buy and Held Target at $292 on, Sep 9th, 2024.
Eric has made no other calls on BIIB in the last 4 months.
There are 12 other peers that have a rating on BIIB. Out of the 12 peers that are also analyzing BIIB, 3 agree with Eric's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $190 on, Friday, August 2nd, 2024
- Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $210 on, Friday, August 2nd, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Hold with Decreased Target to $225 on, Friday, August 2nd, 2024
These are the ratings of the 9 analyists that currently disagree with Eric
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $285 on, Wednesday, September 4th, 2024
- Salim Syed of "Mizuho" Maintained at Buy with Decreased Target to $251 on, Tuesday, August 6th, 2024
- Srikripa Devarakonda of "Truist Securities" Reiterated at Strong Buy with Decreased Target to $302 on, Monday, August 5th, 2024
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $292 on, Friday, August 2nd, 2024
- George Farmer of "Scotiabank" Maintained at Buy with Decreased Target to $244 on, Friday, August 2nd, 2024
- Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $294 on, Monday, July 29th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $313 on, Friday, July 12th, 2024
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 23rd, 2024
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy and Held Target at $340 on, Thursday, May 16th, 2024
Like: 👍
